AOTMiT: Transparency Council on lung cancer, among other things

Agenda:

1. Prepare a position paper on changing the medical technology for the indications underlying the eligibility of adults for palliative and hospice care.
2. Preparation of a position paper on the qualification of the health care benefit "Determination of serum mitotane concentration" as a guaranteed outpatient specialty care benefit.
3. Preparation of a position paper on the evaluation of the drug Rybrevant (amivantamabum) within the framework of the drug program B.6
   "Treatment of patients with lung cancer (ICD-10: C34) and pleural mesothelioma (ICD-10: C45)" -
   1.1 Non-small cell lung cancer patients with activating insertional mutations in exon 20 of EGFR for first-line treatment with amivantamab (intravenous) in combination with carboplatin and pemetrexed.
4. Preparation of a position paper on the evaluation of the drug Rybrevant (amivantamabum) within the framework of the drug program B.6
   "Treatment of patients with lung cancer (ICD-10: C34) and pleural mesothelioma (ICD-10: C45)" -
   1.2 Non-small cell lung cancer patients with deletions in exon 19 or a p.L858R substitution in exon 21 of the EGFR for treatment in the second and subsequent lines with amivantamab (intravenous) in combination with carboplatin and pemetrexed, in patients after failure of prior treatment with a third-generation EGFR tyrosine kinase inhibitor.
5. Preparation of a position on drug evaluation:
   
   • Rybrevant (amivantamabum),
   • Lazcluze (lazertinib),
     under drug program B.6
     "Treatment of patients with lung cancer (ICD-10: C34) and pleural mesothelioma (ICD-10: C45)" -
     Non-small cell lung cancer patients with deletions in exon 19 or a p.L858R substitution in exon 21 of the EGFR for first-line treatment with amivantamab (subcutaneously) in combination with lazertinib.

1. Preparation of a position paper on investigating the appropriateness of issuing reimbursement approvals for the EAA product for the indication: hyperammonemia.
2. Preparation of an opinion on the draft health policy program of the local government unit:
   "Health policy program on early detection of eye defects in children from the city of Poznań".
3. Preparation of an opinion on the draft health policy program of the local government unit:
   "Municipal Program for Promotion of Mental Health of Boguchwała Municipality residents for 2025-2026".

Source: AOTMiT